Vavricka John - Insider Non-Derivative Transactions at Atea Pharmaceuticals, Inc. (AVIR) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Feb 1, 2024, Vavricka John's relationship to Atea Pharmaceuticals, Inc. (AVIR) is Officer (Chief Commercial Officer), and currently has 21,515 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other AVIR insiders.
Data Source: SEC.
Vavricka John - Insider Non-Derivative Transactions of AVIR Common Stock
Vavricka John - Insider Non-Derivative Transactions at AVIR
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Feb 2, 2024 | Sell -- (Common Stock) | 11819 | 3.84 | 21515 |
| Feb 1, 2024 | M -- (Common Stock) | 33334 | 0 | 33334 |